FDA Import Refusal AEK-9734015-0/10002/1 — LAFAGE
The FDA refused shipment AEK-9734015-0/10002/1 from LAFAGE (Costa Rica) on Sep 8, 2026. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- Sep 8, 2026
- Country
- Costa Rica
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75